Literature DB >> 10803748

Pathogenesis of bone erosions in rheumatoid arthritis.

S R Goldring1, E M Gravallese.   

Abstract

Patients with rheumatoid arthritis are at risk for the development of a generalized form of bone loss affecting the axial and appendicular skeleton. In addition, juxta-articular osteopenia and focal erosion of marginal and subchondral bone are commonly seen. The pathogenesis of focal bone erosions is an area of active investigation. Studies of tissue sections from sites of bone erosion in rheumatoid arthritis and in animal models of inflammatory arthritis have identified multinucleated cells with the phenotype of osteoclasts in bone resorption lacunae in these sites, suggesting that osteoclasts mediate a component of this pathologic bone loss. Numerous soluble and cell-membrane factors produced by rheumatoid synovial tissues are likely to play a role in the initiation and progression of bone erosions. In addition, recent studies suggest a role for T lymphocytes and their products in osteoclast-mediated bone loss. This paper reviews the cellular mechanisms and factors implicated in bone erosions in rheumatoid arthritis, and discusses the possible therapeutic strategies suggested by these findings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803748     DOI: 10.1097/00002281-200005000-00006

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  42 in total

Review 1.  The final pathogenetic steps in focal bone erosions in rheumatoid arthritis.

Authors:  S R Goldring
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  [Diagnostic imaging in rheumatology].

Authors:  M Schneider
Journal:  Z Rheumatol       Date:  2002-04       Impact factor: 1.372

3.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

4.  Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts.

Authors:  Hiroyuki Kaneki; Ruolin Guo; Di Chen; Zhenqiang Yao; Edward M Schwarz; Ying E Zhang; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

Review 5.  Multicentric reticulohistiocytosis: a critical review.

Authors:  Carlo Selmi; Adam Greenspan; Arthur Huntley; M Eric Gershwin
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 6.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 7.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

8.  Polymorphisms of interleukin-31 are associated with anti-CCP levels in females with rheumatoid arthritis.

Authors:  Ji-In Yu; Young-Ran Park; Shin-Seok Lee; Soo-Cheon Chae
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

Review 9.  Blockade of co-stimulation in chronic inflammatory diseases.

Authors:  Clemens Scheinecker
Journal:  Wien Med Wochenschr       Date:  2014-10-01

10.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

Authors:  Toshihisa Kawai; Takashi Matsuyama; Yoshitaka Hosokawa; Seicho Makihira; Makoto Seki; Nadeem Y Karimbux; Reginaldo B Goncalves; Paloma Valverde; Serge Dibart; Yi-Ping Li; Leticia A Miranda; Cory W O Ernst; Yuichi Izumi; Martin A Taubman
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.